Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth

A Clinical Overview of Off-label Use of Gabapentinoid Drugs

(2019) Christopher W. Goodman et al.   JAMA Internal Medicine

Lack of correlation between the activity of the mesolimbic dopaminergic system and the rewarding properties of pregabalin in mouse

(2019) Basile Coutens et al.   PSYCHOPHARMACOLOGY

Patterns of gabapentin and pregabalin use and misuse: Results of a population‐based cohort study in France

(2019) Damien Driot et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review

(2019) Saeed Ahmed et al.   Frontiers in Psychiatry

Microglia-neuron interactions in the models of neuropathic pain

(2019) Hidetoshi Tozaki-Saitoh et al.   BIOCHEMICAL PHARMACOLOGY

Pregabalin induces conditioned place preference in the rat during the early, but not late, stage of neuropathic pain

(2018) Yuta Asaoka et al.   NEUROSCIENCE LETTERS

Chronic exposure to insufficient sleep alters processes of pain habituation and sensitization

(2018) Norah S. Simpson et al.   PAIN

Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery

(2018) Tobias Atkin et al.   PHARMACOLOGICAL REVIEWS

Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions

(2018) Olivia C. Eller-Smith et al.   Frontiers in Cellular Neuroscience

The α2δ-1-NMDA Receptor Complex Is Critically Involved in Neuropathic Pain Development and Gabapentin Therapeutic Actions

(2018) Jinjun Chen et al.   Cell Reports

How addictive are gabapentin and pregabalin? A systematic review

(2017) U. Bonnet et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients?

(2017) Jo Nijs et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Peripheral neuropathic pain

(2017) Ralf Baron et al.   PAIN

Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain

(2017) Kirsty Bannister et al.   PAIN

Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database

(2016) Jean-Baptiste Bossard et al.   CLINICAL DRUG INVESTIGATION

Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review

(2016) Rainer Freynhagen et al.   CNS DRUGS

Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use

(2016) Elena P. Calandre et al.   Expert Review of Neurotherapeutics

Do specific NMDA receptor subunits act as gateways for addictive behaviors?

(2016) F. W. Hopf   GENES BRAIN AND BEHAVIOR

Statins for Prevention of Cardiovascular Disease in Adults

(2016) Roger Chou et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sleep Health: Reciprocal Regulation of Sleep and Innate Immunity

(2016) Michael R Irwin et al.   NEUROPSYCHOPHARMACOLOGY

Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use

(2016) Elena P. Calandre et al.   Expert Review of Neurotherapeutics

Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society

(2016) DE Moulin et al.   Pain Research & Management

Gabapentin

(2015) Tracey L. Mersfelder et al.   ANNALS OF PHARMACOTHERAPY

The Brain on Drugs: From Reward to Addiction

(2015) Nora D. Volkow et al.   CELL

The role of sleep in pain and fibromyalgia

(2015) Ernest H. S. Choy   Nature Reviews Rheumatology

Glutamatergic transmission in drug reward: implications for drug addiction

(2015) Manoranjan S. D'Souza   Frontiers in Neuroscience

 2 -1 Signaling in Nucleus Accumbens Is Necessary for Cocaine-Induced Relapse

(2014) S. Spencer et al.   JOURNAL OF NEUROSCIENCE

Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: A potential biomarker of efficacy

(2014) Jennifer Y. Xie et al.   PAIN

Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK

(2013) Vikas Kapil et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Neuropathic pain in the general population: A systematic review of epidemiological studies

(2013) O. van Hecke et al.   PAIN

Poor sleep quality and exaggerated salivary cortisol reactivity to the cold pressor task predict greater acute pain severity in a non-clinical sample

(2012) Burel R. Goodin et al.   BIOLOGICAL PSYCHOLOGY

α2δ expression sets presynaptic calcium channel abundance and release probability

(2012) Michael B. Hoppa et al.   NATURE

Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: A randomized, placebo-controlled, 2-way crossover polysomnography study

(2012) Thomas Roth et al.   ARTHRITIS CARE & RESEARCH

Fibromyalgia and Sleep

(2011) Michael Spaeth et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

(2010) N. Attal et al.   EUROPEAN JOURNAL OF NEUROLOGY

Central Sensitization and CaVα2δ Ligands in Chronic Pain Syndromes: Pathologic Processes and Pharmacologic Effect

(2010) Michael Tuchman et al.   JOURNAL OF PAIN

Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis

(2009) Çagla Eroglu et al.   CELL

Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity

(2009) Alban Latremoliere et al.   JOURNAL OF PAIN

Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin

(2008) Barbara J. Mason et al.   ADDICTION BIOLOGY

The Kyoto protocol of IASP Basic Pain Terminology☆

(2008) John D. Loeser et al.   PAIN